ArticleFrontiers in microbiology2019
Emergence of IncX3 Plasmid-Harboring
Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 33 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed.
- Genomic surveillance and evolution of co-circulating goose parvovirus and waterfowl circovirus in China.Veterinary research · 2026Article
- Two Multidrug-ResistantPathogens (Basel, Switzerland) · 2026Article
- Plasmid-Driven Resistome Diversity in 9700Antibiotics (Basel, Switzerland) · 2026Article
- Cross-species transmission ofFrontiers in cellular and infection microbiology · 2026Review
- Genomic characterization of extended-spectrum β-lactamase-producingApplied and environmental microbiology · 2025Article
- Use of a national repository of Fourier-transform infrared spectroscopy spectra enables fast detection of silent outbreaks and prevention of spread of new antibiotic-resistant sequence types.Antimicrobial resistance and infection control · 2025Article
- Genomic Insights into Bacterial Antimicrobial Resistance Transmission and Mitigation Strategies.Current pharmaceutical biotechnology · 2025Review
- Review
- Rapid Dissemination ofPathogens (Basel, Switzerland) · 2024Article
- High Genetic Diversity in Third-Generation Cephalosporin-ResistantPathogens (Basel, Switzerland) · 2024Article
- Genomic Insights into the First Emergence ofInfection and drug resistance · 2024Article
- A Broad-Spectrum Horizontal Transfer Inhibitor Prevents Transmission of Plasmids Carrying Multiple Antibiotic Resistance Genes.Transboundary and emerging diseases · 2024Article
- Molecular characterization of IncFII plasmid carryingmSphere · 2023Article
- Characterization of NDM-5-ProducingGenes · 2023Article
- Prevalence and Phenotypic and Molecular Characterization of Carbapenemase-Producing Gram-Negative Bacteria in Gabon.The American journal of tropical medicine and hygiene · 2023Article
- Genomic Insights Into the Mechanism of Carbapenem Resistance Dissemination in Enterobacterales From a Tertiary Public Heath Setting in South Asia.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023Article
- Molecular epidemiology and comparative genomics of carbapenemase-producingFrontiers in microbiology · 2023Article
- Emergence and Characterization of Tigecycline Resistance GeneMicrobiology spectrum · 2022Article
- Coexistence ofMicrobiology spectrum · 2022Article
- Molecular Characteristics of Antimicrobial Resistance and Virulence in Klebsiella pneumoniae Strains Isolated from Goose Farms in Hainan, China.Applied and environmental microbiology · 2022Article
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Twelve carbapenem-resistant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.